Domingo Andres
Pascual Figal
Catedraticos de Universidad Vinculados H.V.Arrixaca
King's College Hospital
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von King's College Hospital (4)
2021
-
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: The results of the AFFIRM-AHF study
European Heart Journal, Vol. 42, Núm. 31, pp. 3011-3020
2020
-
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
The Lancet, Vol. 396, Núm. 10266, pp. 1895-1904
2019
-
Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure
European Journal of Heart Failure, Vol. 21, Núm. 12, pp. 1651-1658
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397